Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Assura Plc LSE:AGR London Ordinary Share GB00BVGBWW93 ORD 10P
  Price Change % Change Share Price Shares Traded Last Trade
  -2.00 -2.9% 67.00 2,215,872 16:06:55
Bid Price Offer Price High Price Low Price Open Price
66.90 67.00 68.45 66.85 67.90
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Food & Drug Retailers 136.90 155.80 5.60 12.0 1,981
Last Trade Time Trade Type Trade Size Trade Price Currency
16:06:55 AT 1,232 67.00 GBX

Assura (AGR) Latest News

More Assura News
Assura Investors    Assura Takeover Rumours

Assura (AGR) Discussions and Chat

Assura Forums and Chat

Date Time Title Posts
31/5/202207:19Assura Group1,006

Add a New Thread

Assura (AGR) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
15:06:5567.001,232825.44AT
15:06:3366.939,0356,047.50O
15:06:0866.953,3612,250.19AT
15:06:0866.955,0003,347.50AT
15:03:5566.95237158.67AT
View all Assura trades in real-time

Assura (AGR) Top Chat Posts

DateSubject
29/6/2022
09:20
Assura Daily Update: Assura Plc is listed in the Food & Drug Retailers sector of the London Stock Exchange with ticker AGR. The last closing price for Assura was 69p.
Assura Plc has a 4 week average price of 65.50p and a 12 week average price of 63.10p.
The 1 year high share price is 80.60p while the 1 year low share price is currently 59.30p.
There are currently 2,956,564,843 shares in issue and the average daily traded volume is 5,814,718 shares. The market capitalisation of Assura Plc is £1,980,898,444.81.
31/5/2022
07:19
cwa1: Notice of Dividend Assura plc ("Assura" or "the Company"), the UK's leading primary care property investor and developer, today announces that the next quarterly interim dividend of 0.78 pence per share will be paid on 13 July 2022 to shareholders on the register on 10 June 2022 (the "Record Date"). The Ex-dividend Date will be 9 June 2022.
24/5/2022
12:07
km18: Assura PLC is regarded as a real estate investment trust and primary care property investor and developer. As a result, the firm is specialised in portfolio management and property development, given that the group currently owns 625 modern primary healthcare properties. Given the diversified funding structure, the group optimised rental income to £126.5m from £112m in 2021, leading to a profit hike of 43.9%, from £108.3m to £155.8m. Considering the growing portfolio of properties, earnings per share and assets under management leapt significantly. This plausible market news was reflected on the firm’s P/FCF of 23.9x, signifying that the corporation is able fund its activities effectively. The sudden surge in profits and rental income was incorporated into the P/S of 15.71, which is above most peers in the REIT’s industry. https://wealthoracle.co.uk/detailed-result Keep up to date with WealthOracle AM
24/5/2022
07:48
american idiot: Excellent set of results..... Another strong year delivering portfolio, earnings and dividend growth -- Passing rent roll increased 12% to GBP135.7 million (2021: GBP121.7 million) with WAULT maintained at 11.8 years -- Profit before tax grew 44% to GBP155.8 million (2021: GBP108.3 million) with EPS up 37% at 5.6p (2021: 4.1p) -- EPRA earnings up 14% to GBP86.2 million (2021: GBP75.4 million(1) ) and EPRA EPS of 3.1p (2021: 2.8p(1) ) -- Portfolio value rose 12% to GBP2,752 million (2021: GBP2,453 million) and Net Initial Yield ("NIY") at 4.48% (2021: 4.58%) -- Proposed 5.4% increase in the quarterly dividend to 0.78 pence per share
24/5/2022
07:37
cwa1: https://www.investegate.co.uk/assura-plc--agr-/rns/assura-full-year-results-2022/202205240700054969M/ Jonathan Murphy, CEO, said: "Assura has delivered another year of significant progress, maintaining its strong financial performance and making a positive contribution to the local communities in which it operates. "We have grown our high-quality portfolio to £2.8 billion, progressed our ambitious development pipeline which stands at over £500 million and expanded our offering through working with NHS Trusts, independent providers and making our first investment in Ireland. Supported by our successful bond and equity raises ‒ with accelerated use of proceeds ‒ we have continued to deliver critical new capacity for community healthcare and fulfil the ambitions of our extensive SixBySix social impact strategy. "With the UK's healthcare estate lacking the critical buildings and facilities to tackle the growing backlog of treatments following the pandemic, we know the development of modern, integrated, and high-quality primary care space is a key enabler in reducing this pressure. This area benefits from cross-party political support and Assura is committed to making a significant contribution - all the while accommodating for key emerging trends, including hybrid GP appointments, the requirement for mental health support, and digitalisation. "As the NHS seeks to become the world's first net-zero carbon health system, Assura has continued to roll out initiatives to deliver its strong sustainability plans that support all stakeholders over the year. "Against an uncertain economic backdrop, Assura's steady and reliable business model, strong balance sheet and differentiated market position means it is extremely well positioned to continue growing and delivering shareholder value. We remain confident in Assura's outlook for the coming year and beyond".
16/5/2022
17:11
cwa1: 16 May 2022 Assura plc Change to year end results announcement date Assura plc ("the Company"), the UK's leading primary care property investor and developer, announces that its results for the year ended 31 March 2022 will now be announced on 24 May 2022 and not 18 May 2022 as previously stated. The Group's auditor (Ernst & Young LLP), who were appointed as auditor at the AGM on 6 July 2021, have requested additional time to complete their internal review procedures in their first year. To date, the auditor has not raised any issues to management in respect of the accounts or corporate governance processes. The Group confirms that EPRA EPS and Net Tangible Assets per share for the year ended 31 March 2022 will be modestly ahead of consensus estimates (which are set out on the Group's website) following another year of strong progress. - Ends -
10/3/2022
15:13
cwa1: Hard to fathom the share price of AGR but not complaining currently...
20/2/2022
15:43
tole: My favourite penny stock to buy right now for incomeRupert Hargreaves | Sunday, 20th February, 2022 | More on: AGRPiggy bank group pastel color background Image source: Getty ImagesMy favourite penny stock to buy right now is also an income champion. What's more, while it qualifies as a penny stock, the company has a market capitalization of £1.6bn. This suggests the business has fewer risks than smaller enterprises, which usually fall into the penny share bracket. The company I am talking about is Assura (LSE: AGR). The corporation is a leading primary care property investor and developer. It owns an expanding portfolio of 634 properties in the healthcare sector across the UK. Defensive sector Healthcare is one of the most defensive sectors on the stock market. Property is also generally considered to be a defensive sector. The healthcare property sector combines the benefits of both. Most healthcare facilities are constructed to a specific standard, and they are let on extended leases to providers such as the NHS. With its steady, predictable income stream from the property portfolio, the penny stock has become an income champion over the past five years. At the time of writing, the stock supports a dividend yield of 5%. The payout has grown at a compound annual rate of 5% over the past six years as the company has increased the size of its property portfolio and expanded the rent roll. Assura's management plans to grow the portfolio further over the next couple of years. It has a development pipeline of 22 new schemes, and £71m of portfolio acquisitions were being negotiated at the beginning of the year. As the company has expanded, it has relied heavily on shareholders to provide additional capital. The average number of shares in issue has increased from 1.3bn in 2016 to 2.7bn. This dilution means that as the enterprise has increased the value of its portfolio by around 100% over the past six years, book value per share has risen by just 26%.The potential for further dilution is a significant risk facing investors. The company also has around £1bn of debt. The cost of this debt could increase with higher interest rates. Penny stock buy Despite these challenges, I think the healthcare facilities provider is one of the best investments to buy now for my portfolioIn fact, I think the business has fantastic potential over the next decade. Healthcare spending in the UK is only going to increase.The government has already laid out plans to open up more healthcare facilities across the country to deal with the current NHS backlog. This presents a fantastic opportunity for the group to acquire and build new facilities to meet the demand from the health service.With demand for these facilities set to grow in the years ahead, it looks as if Assura's dividend payout can continue to rise over the next decade and beyond. Considering its income and growth potential, I would be happy to buy the penny stock.
18/2/2022
17:02
steve3sandal: Nothing wrong with PHP results this week but AGR NAV premium has all but disappeared on an average of the various metrics. I’ve topped up again this afternoon at 60.something a full 3p below my last top up a week ago! Huh!
13/1/2022
17:00
cwa1: Over 30 million traded today, solid volume if not share price
22/10/2021
19:27
tole: I'd buy this UK penny share for its dividend growth potentialChristopher Ruane | Thursday, 21st October, 2021 | More on: AGROne pound coin Image source: Getty Images.Just because a share trades in pennies not pounds doesn't necessarily mean the company isn't attractive. One UK penny share I have been considering for my portfolio has a strong record of dividend growth. I also think it could keep increasing its payout. Below I look at the share in more detail.UK penny share with healthcare exposureThe UK penny share in question is Assura (LSE: AGR). Although the shares trade in pennies, this isn't a small company. In fact, the Assura market capitalisation is almost £2bn.It owns and leases a property portfolio focussing on the healthcare sector. So typical tenants include primary care providers such as GPs. I like that strategy for a number of reasons. First, demand is likely to be consistent. The need for primary care provision will remain no matter what happens to the economy. That will likely involve a requirement for physical space in central locations. Even if doctors do more virtual consultations – and lots of dissatisfied patients are arguing that they shouldn't – they will still need a physical working space.Secondly, GP surgeries seem like good tenants to me. They have the resources to pay the rent on time. They are also unlikely to make dramatic changes to buildings like some industrial tenants may do. So, when a lease ends, it is easier to lease the building quickly again.The company said this month that it has added a net total of 16 new properties to its portfolio in the previous six months. It now has 625 properties, with current annualised rent due of around £128m.Assura's dividend attracts meThat business model allows Assura to pay a dividend. Currently, the shares yield 3.9%. I think that is attractive enough to consider adding this UK penny share to my portfolio.But I also like the company's progressive dividend policy. It typically pays out quarterly. The quarterly dividend stands at 0.74p, around 4% higher than the previous year. Assura has raised the quarterly dividend annually since payouts began in 2012. Back then, the dividend was just 0.285p per share. That means that over the past 11 years, Assura'a dividend has had a compound annual growth rate of 11.2%. That is excellent in my view, and reflects the cash generation possibilities of the business model.Assura share price risksWhile a track record of double-digit annual increases attracts me, dividend history is not necessarily a guide to future payouts. With net debt of £1bn, Assura needs to pay substantial interest. If that cost increases, it could hurt future dividend payment ability. There is also a risk that any reshaping of healthcare delivery could lead to shifting demand for property leases from primary care providers. Over time, that could damage revenues and profits.Nonetheless, I like Assura's business model and its dividend appeal. The shares are actually cheaper to buy now than they were a year ago, having lost 4% of their value over 12 months. I'd consider picking them up and tucking them away in my portfolio today.
Assura share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
AGR
Assura
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220629 15:22:56